These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9602957)

  • 1. The effects of eprosartan, an angiotensin II AT1 receptor antagonist, on uric acid excretion in patients with mild to moderate essential hypertension.
    Ilson BE; Martin DE; Boike SC; Jorkasky DK
    J Clin Pharmacol; 1998 May; 38(5):437-41. PubMed ID: 9602957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.
    Puig JG; Mateos F; Buño A; Ortega R; Rodriguez F; Dal-Ré R
    J Hypertens; 1999 Jul; 17(7):1033-9. PubMed ID: 10419078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AT1 blockers and uric acid metabolism: are there relevant differences?
    Puig JG; Torres R; Ruilope LM
    J Hypertens Suppl; 2002 Jun; 20(5):S29-31. PubMed ID: 12184060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study to assess the renal hemodynamic, vascular, and hormonal effects of eprosartan, an angiotensin II AT1-receptor antagonist, in sodium-replete healthy men.
    Ilson BE; Boike SC; Martin DE; Freed MI; Zariffa N; Jorkasky DK
    Clin Pharmacol Ther; 1998 Apr; 63(4):471-81. PubMed ID: 9585802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and tolerance of one or two daily doses of eprosartan in essential hypertension. The Eprosartan Multinational Study Group.
    Hedner T; Himmelmann A
    J Hypertens; 1999 Jan; 17(1):129-36. PubMed ID: 10100104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eprosartan, an angiotensin II receptor antagonist, does not affect the pharmacodynamics of glyburide in patients with type II diabetes mellitus.
    Martin DE; DeCherney GS; Ilson BE; Jones BA; Boike SC; Freed MI; Jorkasky DK
    J Clin Pharmacol; 1997 Feb; 37(2):155-9. PubMed ID: 9055142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome.
    Masajtis-Zagajewska A; Majer J; Nowicki M
    J Renin Angiotensin Aldosterone Syst; 2021; 2021():2214978. PubMed ID: 34527078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double blind randomized trial to compare the effects of eprosartan and enalapril on blood pressure, platelets, and endothelium function in patients with essential hypertension.
    Leu HB; Charng MJ; Ding PY
    Jpn Heart J; 2004 Jul; 45(4):623-35. PubMed ID: 15353873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
    Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
    Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
    Punzi HA; Punzi CF
    J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADEPT: Addition of the AT1 receptor antagonist eprosartan to ACE inhibitor therapy in chronic heart failure trial: hemodynamic and neurohormonal effects.
    Murdoch DR; McDonagh TA; Farmer R; Morton JJ; McMurray JJ; Dargie HJ
    Am Heart J; 2001 May; 141(5):800-7. PubMed ID: 11320369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eprosartan: a review of its use in the management of hypertension.
    Plosker GL; Foster RH
    Drugs; 2000 Jul; 60(1):177-201. PubMed ID: 10929934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central inhibition of AT1receptors by eprosartan--in vitro autoradiography in the brain.
    Muders F; Palkovits M; Bahner U; Kirst I; Elsner D; Jandeleit-Dahm K
    Pharmacol Res; 2001 Mar; 43(3):251-5. PubMed ID: 11401417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of eprosartan on reflex sympathetic activation in sodium restricted patients with essential hypertension.
    Vase H; Lauridsen TG; Graffe CC; Pedersen EB
    J Am Soc Hypertens; 2011; 5(5):385-94. PubMed ID: 21640689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group.
    Gradman AH; Gray J; Maggiacomo F; Punzi H; White WB
    Clin Ther; 1999 Mar; 21(3):442-53. PubMed ID: 10321414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of eprosartan in severe hypertension. Eprosartan Multinational Study Group.
    Sega R
    Blood Press; 1999; 8(2):114-21. PubMed ID: 10451039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension.
    White WB; Anwar YA; Mansoor GA; Sica DA
    Am J Hypertens; 2001 Dec; 14(12):1248-55. PubMed ID: 11775134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eprosartan: an angiotensin-II receptor antagonist for the management of hypertension.
    Cheng-Lai A
    Heart Dis; 2002; 4(1):54-9. PubMed ID: 11975834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.
    Martin DE; Tompson D; Boike SC; Tenero D; Ilson B; Citerone D; Jorkasky DK
    Br J Clin Pharmacol; 1997 Jun; 43(6):661-4. PubMed ID: 9205830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
    Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.